Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(13 sites)

United States

UC San Diego Moores Cancer Center, La Jolla, California

Emory University Hospital Midtown, Atlanta, Georgia

Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia

Emory Saint Joseph's Hospital, Atlanta, Georgia

Northwestern University, Chicago, Illinois

National Institutes of Health Clinical Center, Bethesda, Maryland

NCI - Center for Cancer Research, Bethesda, Maryland

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

NYU Langone Hospital - Long Island, Mineola, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania

M D Anderson Cancer Center, Houston, Texas